1623 Capital LLC Verve Therapeutics, Inc. Transaction History

1623 Capital LLC

  • $0
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$11.14 - $23.17 $90,880 - $189,020
8,158 Added 43.3%
26,999 $413,000
Q1 2022

May 13, 2022
SELL
$20.92 - $39.36 $20,208 - $38,021
-966 Reduced 4.88%
18,841 $430,000
Q4 2021

Feb 11, 2022
BUY
$31.94 - $54.82 $632,635 - $1.09 Million
19,807 New
19,807 $730,000

Others Institutions Holding VERV

# of Institutions
186
Shares Held
73.3M
Call Options Held
85K
Put Options Held
215K
View Full List

About Verve Therapeutics, Inc.

VERV Quotes by TradingView
  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $291M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track 1623 Capital LLC Portfolio

Follow 1623 Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1623 Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1623 Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email